Researchers have identified a compound that could block certain life-threatening and hard-to-treat allergic reactions.

According to the American College of Allergy Asthma and Immunology, nearly one in three U.S. adults report having a seasonal allergy, eczema or food allergy.

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in ...

AB Science will be granted a patent, valid through 2040, covering the medical use of masitinib as a treatment for sickle cell ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

Jasper Therapeutics, Inc.’s JSPR share price has surged by 7.05%, which has investors questioning if this is right time to ...